Nektar Therapeutics

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$60.98

+0.06 (+0.10%)

As of Jun 21, 10:15 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 88%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target -30.7% upside

Low Target $31.85

Average Target $42.23

High Target $63.47

Current Price $60.98

Current
$60.98

Target
$42.23

$31.85 $42.23 avg $63.47

Scenario Analysis

Bear Case

$31.85

-47.8%

Low target

Base Case

$42.23

-30.7%

Avg target

Bull Case

$63.47

+4.1%

High target

Risk/Reward

0.1x

Unfavorable

Price in Context

52-Week High

$109.00

-44.1% from high

52-Week Low

$8.27

+637.4% from low

Target vs 52W High

$42.23

-61.3% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	79%	$1,330.33	+20.2%
RDY Dr. Reddy's Laboratories	Sell	44	50%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+25.3%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+33.2%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+37.1%
BMY Bristol-Myers Squibb Co	Hold	36	39%	$174.50	+214.2%
ZTS Zoetis Inc	Buy	24	58%	$209.87	+173.1%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-34.5%